Annas, G. J. 1982. Mandatory PKU screening: The other side of the looking glass. Am. J. Public Health 72:1401-1403.

Auger, I., P. Thomas, V. De Gruttola, D. Morse, D. Moore, R. Williams, B. Truman, and C. E. Lawrence. 1988. Incubation periods for paediatric AIDS patients. Nature 336:575-577.

Barbacci, M., T. Quinn, R. Kline, J. Repke, and R. Chaisson. 1989a. Failure of targeted screening to identify HIV+ pregnant women. P. 222 in Abstracts of the Fifth International Conference on AIDS, Montreal, Canada, June 4-9.

Barbacci, M., R. Chaisson, J. Anderson, and J. Horn. 1989b. Knowledge of HIV serostatus and pregnancy decisions. P. 223 in Abstracts of the Fifth International Conference on AIDS, Montreal, Canada, June 4-9.

Bayer, R. 1989. Perinatal transmission of HIV infection: The ethics of prevention. Clin. Obstet. Gynecol. 32:497-505.

Benenson, A. S., K. M. Peddecord, L. K. Hofherr, M. S. Ascher, R. N. Taylor, and T. L. Hearn. 1990. Reporting the results of human immunodeficiency virus testing. J. Am. Med. Assoc. 262:3435-3438.

Biggar, R. J., S. Pahwa, H. Minkoff, H. Mendes [sic], A. Willoughby, S. Landesman, and J. J. Goedert. 1989. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am. J. Obstet. Gynecol. 161:1239-1244.

Blanche, S., C. Rouzioux, M.-L. G. Moscato, F. Veber, M.-J. Mayaux, C. Jacomet, J. Tricoire, A. Deville, M. Vial, G. Firtion, A. de Crepy, D. Douard, M. Robin, C. Courpotin, N. Ciraru-Vigneron, F. le Deist, C. Griscelli, and the HIV Infection in Newborns French Collaborative Study Group. 1989. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N. Engl. J. Med. 320:1643-1648.


CDC (Centers for Disease Control). 1985. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. Morbid. Mortal. Wkly. Rep. 34:721-726, 731-732.

CDC (Centers for Disease Control). 1986. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendation of the Immunization Practices Advisory Committee. Morbid Mortal Wkly. Rep. 35:595-605.

CDC (Centers for Disease Control). 1987a. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morbid Mortal Wkly. Rep. 36:509-515.

CDC (Centers for Disease Control). 1987b. Recommendations for prevention of HIV transmission in health-care settings. Morbid Mortal Wkly. Rep. 36:1S-18S.

CDC (Centers for Disease Control). 1989a. General recommendations on immunization. Recommendations of the Immunization Practices Advisory Committee. Morbid Mortal Wkly. Rep. 38:205-227.

CDC (Centers for Disease Control). 1989b. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Morbid Mortal. Wkly. Rep. 38(S-5):1-9.

CDC (Centers for Disease Control). 1990. HIV/AIDS Surveillance Report . September:1-18. Chavkin, W. 1990. Drug addiction and pregnancy: Policy crossroads. Am. J. Public Health 80:483-487.

Choi, K.-H., L Wermuth, and J. Sorensen. 1990. Predictors of condom use among women sexual partners of intravenous drug users. P. 271 in Abstracts of the Sixth International Conference on AIDS, Vol. 2, San Francisco, California, June 20-24.

Chu, S. Y., J. W. Buehler, and R. L. Berkelman. 1990. Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States J. Am. Med. Assoc. 264:225-229.

Coates, T. J., R. D. Stall, S. M. Kegeles, B. Lo, S. F. Morin, and L. McKusick. 1988. AIDS antibody testing: Will it stop the AIDS epidemic? Will it help people infected with HIV? Am. Psychologist 43:859-864.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement